Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Vosaroxin

Vosaroxin

Vosaroxin structure

Vosaroxin 

structure
  • CAS No:

    175414-77-4

  • Formula:

    C18H19N5O4S

  • Chemical Name:

    Vosaroxin

  • Synonyms:

    1,8-Naphthyridine-3-carboxylic acid,1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-;1,8-Naphthyridine-3-carboxylic acid,1,4-dihydro-7-[3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-,(3S-trans)-;1,4-Dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid;(+)-AG-7352;AG 7352;SNS 595;SPC 595;Vosaroxin

  • Categories:

    Biochemical Engineering  >  Inhibitors

Description

Voreloxin is a first-in-class topoisomerase II inhibitor that intercalates DNA and induces site-selective DNA DSB, G2 arrest, and apoptosis.


Vosaroxin is under investigation for the treatment of Leukemia, Myeloid, Acute.|Vosaroxin is a small molecule and a naphthyridine analogue with antineoplastic activity. Vosaroxin intercalates into DNA in a site-specific manner and blocks the re-ligation process carried out by topoisomerase II during DNA replication. As a result, inhibition of DNA replication, RNA and protein synthesis occurs, followed by cell cycle arrest at G2 phase and induced p53-independent apoptosis. This agent shows a favorable toxicity profile in several aspects: it does not generate reactive oxygen species, as do anthracyclines, hence reducing the risk of cardiotoxicity; it is not a P-glycoprotein (P-gp) substrate, and thereby evades the common mechanism for multidrug resistance; and it has limited distribution to normal tissues and a more chemically stable molecular structure.

Vosaroxin Basic Attributes

401.441

401.44

K6A90IIZ19

C95148

L - Antineoplastic and immunomodulating agents

Characteristics

136

-0.51

1.5±0.1 g/cm3

652.0±65.0 °C at 760 mmHg

348.1±34.3 °C

1.703

Drug Information

Treatment of acute myeloid leukaemia

1,4-dihydro-7-(3-methoxy-4-methylamino-1-pyrrolidinyl)-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid

Vosaroxin Use and Manufacturing

Human drugs -> Rare disease (orphan)|Human Drugs -> EU pediatric investigation plans

Computed Properties

Molecular Weight:401.4
XLogP3:-0.3
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:10
Rotatable Bond Count:5
Exact Mass:401.11577528
Monoisotopic Mass:401.11577528
Topological Polar Surface Area:136
Heavy Atom Count:28
Complexity:662
Defined Atom Stereocenter Count:2
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Recommended Suppliers of Vosaroxin

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.